851 related articles for article (PubMed ID: 23721855)
21. Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway.
Lv X; Lv GH; Dai GY; Sun HM; Xu HQ
Chin J Nat Med; 2016 Nov; 14(11):844-855. PubMed ID: 27914528
[TBL] [Abstract][Full Text] [Related]
22. Association between promoter polymorphism (-108C>T) of paraoxonase1 gene and it
Shakeri R; Khajeniazi S; Marjani A
Clin Chim Acta; 2017 Nov; 474():34-37. PubMed ID: 28866115
[TBL] [Abstract][Full Text] [Related]
23. Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients.
Buraczynska M; Zaluska W; Buraczynska K; Markowska-Gosik D; Ksiazek A
Hum Immunol; 2015 Nov; 76(11):843-8. PubMed ID: 26429324
[TBL] [Abstract][Full Text] [Related]
24. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
25. The influence of PON1 192 polymorphism on endothelial function in diabetic subjects with or without hypertension.
Irace C; Cortese C; Fiaschi E; Scavelli F; Liberatoscioli L; Federici G; Gnasso A
Hypertens Res; 2008 Mar; 31(3):507-13. PubMed ID: 18497471
[TBL] [Abstract][Full Text] [Related]
26. Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease.
Wong FN; Chua KH; Kuppusamy UR; Wong CM; Lim SK; Tan JA
PeerJ; 2016; 4():e1908. PubMed ID: 27114872
[TBL] [Abstract][Full Text] [Related]
27. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
28. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
29. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
Saito R; Araki S; Yamamoto Y; Kusuhara K
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
[TBL] [Abstract][Full Text] [Related]
30. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.
Tsuzura S; Ikeda Y; Suehiro T; Ota K; Osaki F; Arii K; Kumon Y; Hashimoto K
Metabolism; 2004 Mar; 53(3):297-302. PubMed ID: 15015140
[TBL] [Abstract][Full Text] [Related]
31. Association of RAGE gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
Gao J; Teng J; Liu H; Han X; Chen B; Xie A
Neurosci Lett; 2014 Jan; 559():158-62. PubMed ID: 24304868
[TBL] [Abstract][Full Text] [Related]
32. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
[TBL] [Abstract][Full Text] [Related]
33. Functional promoter polymorphisms of the receptor for advanced glycation end products in children and adolescents with type 1 diabetes.
Gomes LC; Welter M; Gobor LC; Santos-Weiss ICR; França SN; Alberton D; Picheth G; Rego FG
Mol Cell Probes; 2015 Dec; 29(6):503-506. PubMed ID: 26456846
[TBL] [Abstract][Full Text] [Related]
34. The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis.
Lu W; Feng B
Tohoku J Exp Med; 2010 Apr; 220(4):291-7. PubMed ID: 20410680
[TBL] [Abstract][Full Text] [Related]
35. RAGE gene polymorphism and environmental factor in the risk of oral cancer.
Su S; Chien M; Lin C; Chen M; Yang S
J Dent Res; 2015 Mar; 94(3):403-11. PubMed ID: 25582438
[TBL] [Abstract][Full Text] [Related]
36. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.
Buraczynska M; Zukowski P; Ksiazek K; Wacinski P; Dragan M
Diabetes Res Clin Pract; 2016 Jun; 116():7-13. PubMed ID: 27321310
[TBL] [Abstract][Full Text] [Related]
37. Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
Sozer V; Himmetoglu S; Korkmaz GG; Kaya S; Aydin S; Yumuk V; Hatemi H; Uzun H
Minerva Med; 2014 Jun; 105(3):237-44. PubMed ID: 24988089
[TBL] [Abstract][Full Text] [Related]
38. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
[TBL] [Abstract][Full Text] [Related]
39. Association of RAGE (p.Gly82Ser) and MnSOD (p.Val16Ala) polymorphisms with diabetic retinopathy in T2DM patients from north India.
Vanita V
Diabetes Res Clin Pract; 2014 Apr; 104(1):155-62. PubMed ID: 24529564
[TBL] [Abstract][Full Text] [Related]
40. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
Letellier C; Durou MR; Jouanolle AM; Le Gall JY; Poirier JY; Ruelland A
Diabetes Metab; 2002 Sep; 28(4 Pt 1):297-304. PubMed ID: 12442067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
